Research continues into anti-BAFF drugs for anxiety and selective serotonin reuptake inhibitors for depression, given their potential roles in the inflammatory processes associated with SS-related fatigue (Schlesinger et al., 2011; Vivino et al., 2016; Bodewes et al., 2019). This evidence concerns the gene TNFSF13B and depressive symptom measurement.